The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study

Phase 2 Active not recruiting 205 enrolled Washington State University

RandomizedParallel-groupTriple-blindTreatment

Summary

A phase II randomized, double-blind, placebo-controlled clinical trial (RCT) to evaluate the ability of zonisamide (ZON) to decrease alcohol use among treatment-seeking adults with an alcohol use disorder (AUD).

Timeline

Start: 2022-01-07
Primary completion: 2027-08-31
Completion: 2027-08-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Zonisamide	Other / unclassified	500 mg	—

The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study

Summary

Timeline

Drugs

Indications